DoctorTro
80.2K posts

DoctorTro
@DoctorTro
Physician | Father | CMO @GoTowardHealth | ❤️🩹I help companies ⬇️ healthcare costs |💪🏻I help patients lose weight, improve diabetes | https://t.co/9COUe2aacl
We see patients NATIONWIDE Katılım Aralık 2010
464 Takip Edilen167.6K Takipçiler

@DoctorTro Exactly Dr Tro! For the last decade I have experienced joy & thriving health with full satiation through beef & eggs. No counting calories or portion sizes ever again. Eat until I am full, then enjoy the rest of my day.
English

In Tell’s critique, she argues that cardiologists rely on a reputation built on patients living longer, while overlooking the underlying incentive structure that rewards volume and pharmacologic management.
My model is fundamentally different.
Compensation is directly tied to outcomes.
No improvement in A1c or weight… no revenue.
No sustained patient benefit… no business.
This is not theoretical alignment… it is enforced accountability.
The dataset being presented is not fringe. It reflects large, real-world populations that challenge entrenched assumptions. The resistance to it is not methodological… it is ideological.
The use of terms like “grifter” is not an argument. It is a substitute for one.
If the standard is that cardiologists function on reputation, then that standard applies across medicine. The distinction is not specialty… it is whether incentives are aligned with outcomes or with volume.
They don’t understand financial structure enough to even understand that grift is collecting payments for visits for refills and not outcomes
I would been embarrassed if I was them
English

@Tellit007 @DoctorTro You may find this paper interesting 😊
Austin Dudzinski, PharmD, BCACP@ApoDudz
“Our findings indicate that HMGCR inhibitors [statins] were significantly associated with an increased risk of diabetic nephropathy, diabetic retinopathy, and diabetic neuropathy. PCSK9 inhibitors increase the risk of diabetic nephropathy and diabetic neuropathy. Furthermore, NPCILI inhibitors can reduce the risk of diabetic retinopathy."
English

Interesting JAMA study from 2018 showing that in patients with diabetes, lower LDL is associated with WORSE outcomes for nerve health
It’s as if the body may use cholesterol to heal nerves? 🤔
jamanetwork.com/journals/jaman…
English

@DoctorTro Mine was 0, CTA showed 25% in LAD.
Now what? It's all confusing.
English

@GeorgiaEdeMD Listen to The Low Carb MD Podcast across all platforms:
YouTube: @LowCarbMDPodcast" target="_blank" rel="nofollow noopener">youtube.com/@LowCarbMDPodc…
Website: lowcarbmd.com
Patreon: patreon.com/LowCarbMD
Spotify: open.spotify.com/show/01BcQ7qFw…
iTunes: podcasts.apple.com/us/podcast/low…
English

There are certain ways of eating that are bioLOGICALLY beneficial and natural for humans. Dr. Georgia Ede (@GeorgiaEdeMD) explains why this one particular dietary philosophy is especially bio-ILLOGICAL.
English

Everything wrong with cardiology in one tweet
Vern Vanderkleed@wiseoldguy
@DoctorTro I had a Cleerly scan showing zero plaque and my doctor still wants to lower my LDL.
English

@Hypno_gasman Carotid and femoral ultrasound can be done point of care
English

@DoctorTro CAC looks at calcified plaques. They aren’t the plaques at risk of rupture. CAC misses soft plaques.
English

Doctors say they avoid ordering a coronary artery calcium scan because “it won’t change management.”
Think about what that means.
A test that directly measures atherosclerotic plaque in the coronary arteries is dismissed because it might challenge a treatment algorithm based entirely on risk calculators and cholesterol numbers.
The reality is simpler.
Many physicians avoid CAC because it creates uncomfortable situations:
A 45-year-old with high LDL but CAC = 0
A 60-year-old with “normal labs” but CAC = 400
Now the conversation becomes harder.
Guidelines become less convenient.
And the doctor actually has to explain risk.
CAC doesn’t fit neatly into pharmaceutical pathways… but it tells you something far more important:
Do you actually have plaque?
English

Your future health isn’t written yet… unless you ignore it.
Visit our website to get started: toward.health
English

@DoctorTro I am assuming if i stay on Crestor my end result will be Type 2. Need to have a discussion with my Cardiologist. Why do I feel I am going to "love" (sarcastic) his reaction to why I need to stay on it?
English

You are incorrect.
My approach addresses not only established risk factors, but also the next layer of drivers that most practices have not yet begun to evaluate or manage.
When services are offered without accountability, outcomes are not prioritized. When employer-based fees are tied to performance, incentives change.
That alignment shifts focus away from dogma and toward measurable results.
English

@DoctorTro Only issue with your paradigm is that ppl with zero plaque can still have events — and if you have a lot of risk factors — a lot of events : look at FRS scores > 16 with zero scores ..


English